Epithalon vs MOTS-c · Mechanism, Dose, Cited Research

Side-by-side

	Epithalon	MOTS-c
Mechanism	Tetrapeptide; telomerase modulation and pineal-function research.	Mitochondrial-derived peptide; AMPK activation.
Half-life	Short.	Short.
Dose	5-10 mg daily SC.	5-10 mg × 3 weekly SC.
Cycle	10-20 day pulse, 2×/year.	8-12 weeks.
Research context	Khavinson programme; Soviet-era data; limited Western replication¹.	AMPK activation; exercise-induced expression; preclinical metabolic data².
Cost tier	Low-to-mid.	Mid.

Epithalon and MOTS-c are both "longevity" peptides but target completely different cellular-aging mechanisms. Epithalon is a tetrapeptide from the Khavinson programme, investigated for telomerase activation and pineal-gland effects¹. The strongest evidence comes from Soviet-era research with limited Western replication; mechanisms and effect sizes should be treated with appropriate caution in research contexts.

MOTS-c is mechanistically more modern and better-characterised². It is a 16-amino-acid mitochondrial-encoded peptide that activates AMPK and appears to regulate metabolic flexibility and exercise-induced adaptation. The peptide itself is exercise-induced, which ties its biology to the endogenous stress-response pathway. Preclinical data show improvements in insulin sensitivity and age-related physical decline in animal models.

Research protocols select one or the other based on the research question. A researcher working on telomere biology, senescence markers, or pineal-related endpoints selects Epithalon, while accepting the evidence-base limitations. A researcher working on metabolic flexibility, mitochondrial function, or exercise-biology endpoints selects MOTS-c. The two are rarely stacked because their hypothesised mechanisms are largely independent. See Epithalon telomerase research and MOTS-c mitochondrial research.

Frequently asked

Is Epithalon evidence-based?

The evidence base is preclinical and predominantly from the Khavinson/Soviet-era programme¹. Western replication is limited. Research use should treat claims about telomerase activation and life-extension as hypothesis-stage.

Is MOTS-c better characterised?

Mechanistically yes. MOTS-c's AMPK-activation pathway is well-described and its preclinical data is contemporary². But long-term human data is still limited.

Can they be combined?

Mechanisms do not overlap, so combination is mechanistically coherent. Research protocols combining them exist but the evidence base for synergy is minimal.

Research desk

Ordering both Epithalon and MOTS-c for a research protocol? The Bangkok desk handles pricing, COA, and timing on WhatsApp.

Open a line with the research desk ≥98% HPLC purity · supplier COA on file · Bangkok-based

Go deeper

Related comparisons

References

Khavinson VK, et al. Peptide Epitalon activates chromatin at the old age. Neuro Endocrinol Lett. 2003. PMID: 14647006
Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metab. 2015. PMID: 25738459

All references verified against PubMed via NCBI E-utilities.